IGF1 and RASopathy: On the basis of the collected data, we suggest that that the combination of several factor including the dysregulation of the RAS-MAPK pathway, the reduced physical activity, the presence of inflammatory cytokines and the impaired IGF1 activity might contribute to the impaired bone metabolism in patients with RASopathy.